摘要 |
<p>A pharmaceutical composition comprised of Taxol®, Taxotere®, or derivatives and a cyclin-dependent kinase is described, as well as a form of administration wherein the taxane is given intermittently and the cyclin-dependent kinase is given repeatedly within the same cycle.</p> |